BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38467732)

  • 21. Molecular analysis of the APC gene in Sicilian patients with familial adenomatous polyposis (F.A.P.).
    Russo A; Catania VE; Cavallaro A; Ficili B; Lanteri E; Tralongo P; Cappellani A; Randazzo C; Cammisuli F; Madeddu R; Trichilo V; Libra M; Travali S
    Int J Surg; 2014; 12 Suppl 2():S125-S129. PubMed ID: 25183641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel large germ line deletion in adenomatous polyposis coli (APC) gene associated with familial adenomatous polyposis.
    Pouya F; Mojtabanezhad Shariatpanahi A; Ghaffarzadegan K; Tabatabaee Yazdi SA; Golmohammadzadeh H; Soltani G; Aminian Toosi K; Kerachian MA
    Mol Genet Genomic Med; 2018 Nov; 6(6):1031-1040. PubMed ID: 30259713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric polyposis and desmoid tumours as a new familial adenomatous polyposis clinical variant associated with
    Disciglio V; Fasano C; Cariola F; Forte G; Grossi V; Sanese P; Lepore Signorile M; Resta N; Lotesoriere C; Stella A; Lolli I; Simone C
    J Med Genet; 2020 May; 57(5):356-360. PubMed ID: 31591141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas.
    Sieber OM; Lamlum H; Crabtree MD; Rowan AJ; Barclay E; Lipton L; Hodgson S; Thomas HJ; Neale K; Phillips RK; Farrington SM; Dunlop MG; Mueller HJ; Bisgaard ML; Bulow S; Fidalgo P; Albuquerque C; Scarano MI; Bodmer W; Tomlinson IP; Heinimann K
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2954-8. PubMed ID: 11867715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients.
    Elsayed FA; Tops CMJ; Nielsen M; Morreau H; Hes FJ; van Wezel T
    Fam Cancer; 2022 Jan; 21(1):79-83. PubMed ID: 33683519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel pathogenic germline mutation in the adenomatous polyposis coli gene in a Chinese family with familial adenomatous coli.
    Jiang SS; Li JJ; Li Y; He LJ; Wang QJ; Weng DS; Pan K; Liu Q; Zhao JJ; Pan QZ; Zhang XF; Tang Y; Chen CL; Zhang HX; Xu GL; Zeng YX; Xia JC
    Oncotarget; 2015 Sep; 6(29):27267-74. PubMed ID: 26311738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of a heterozygous germline APC mutation in a three-generation family with familial adenomatous polyposis using targeted massive parallel sequencing in Vietnam.
    Giang H; Nguyen VT; Nguyen SD; Nguyen HP; Vo BT; Nguyen TM; Nguyen NH; Truong KD; Do TT; Phan MD; Nguyen HN
    BMC Med Genet; 2018 Oct; 19(1):188. PubMed ID: 30340471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characterization and mutation spectrum in patients with familial adenomatous polyposis in China.
    Li N; Kang Q; Yang L; Zhao XJ; Xue LJ; Wang X; Li AQ; Li CG; Sheng JQ
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1497-1503. PubMed ID: 31062380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colon cancer prevention by detection of APC gene mutation in a family with attenuated familial adenomatous polyposis.
    Poovorawan K; Suksawatamnuay S; Sahakitrungruang C; Treeprasertsuk S; Wisedopas N; Komolmit P; Poovorawan Y
    Asian Pac J Cancer Prev; 2012; 13(10):5101-4. PubMed ID: 23244118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.
    Cruz-Correa M; Diaz-Algorri Y; Mendez V; Vazquez PJ; Lozada ME; Freyre K; Lathroum L; Gonzalez-Pons M; Hernandez-Marrero J; Giardiello F; Rodriguez-Quilichini S
    Fam Cancer; 2013 Sep; 12(3):555-62. PubMed ID: 23460355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APC transcription studies and molecular diagnosis of familial adenomatous polyposis.
    Short E; Thomas LE; Davies A; Bolton A; Maynard J; Giles P; Mort M; Consoli C; Egner I; Jundi H; Sampson JR
    Eur J Hum Genet; 2020 Jan; 28(1):118-121. PubMed ID: 31383941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in
    Nieminen TT; Walker CJ; Olkinuora A; Genutis LK; O'Malley M; Wakely PE; LaGuardia L; Koskenvuo L; Arola J; Lepistö AH; Brock P; Yilmaz AS; Eisfeld AK; Church JM; Peltomäki P; de la Chapelle A
    Thyroid; 2020 Mar; 30(3):380-388. PubMed ID: 32024448
    [No Abstract]   [Full Text] [Related]  

  • 33. Variant profiling of colorectal adenomas from three patients of two families with MSH3-related adenomatous polyposis.
    Perne C; Peters S; Cartolano M; Horpaopan S; Grimm C; Altmüller J; Sommer AK; Hillmer AM; Thiele H; Odenthal M; Möslein G; Adam R; Sivalingam S; Kirfel J; Schweiger MR; Peifer M; Spier I; Aretz S
    PLoS One; 2021; 16(11):e0259185. PubMed ID: 34843512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature.
    Nieuwenhuis MH; Vasen HF
    Crit Rev Oncol Hematol; 2007 Feb; 61(2):153-61. PubMed ID: 17064931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
    Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
    Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers.
    Ghorbanoghli Z; Nieuwenhuis MH; Houwing-Duistermaat JJ; Jagmohan-Changur S; Hes FJ; Tops CM; Wagner A; Aalfs CM; Verhoef S; Gómez García EB; Sijmons RH; Menko FH; Letteboer TG; Hoogerbrugge N; van Wezel T; Vasen HF; Wijnen JT
    Fam Cancer; 2016 Oct; 15(4):563-70. PubMed ID: 26880076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resorting the function of the colorectal cancer gatekeeper adenomatous polyposis coli.
    Kariv R; Caspi M; Fliss-Isakov N; Shorer Y; Shor Y; Rosner G; Brazowski E; Beer G; Cohen S; Rosin-Arbesfeld R
    Int J Cancer; 2020 Feb; 146(4):1064-1074. PubMed ID: 31283021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing.
    Rohlin A; Rambech E; Kvist A; Törngren T; Eiengård F; Lundstam U; Zagoras T; Gebre-Medhin S; Borg Å; Björk J; Nilbert M; Nordling M
    Fam Cancer; 2017 Apr; 16(2):195-203. PubMed ID: 27696107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis cases.
    Spier I; Drichel D; Kerick M; Kirfel J; Horpaopan S; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Perner S; Hoffmann P; Kristiansen G; Timmermann B; Nöthen MM; Holinski-Feder E; Schweiger MR; Aretz S
    J Med Genet; 2016 Mar; 53(3):172-9. PubMed ID: 26613750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Singapore familial adenomatous polyposis (FAP) patients with classical adenomatous polyposis but undetectable APC mutations have accelerated cancer progression.
    Cao X; Hong Y; Eu KW; Loi C; Cheah PY
    Am J Gastroenterol; 2006 Dec; 101(12):2810-7. PubMed ID: 17026565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.